FDA 510(k)

MODIFICATION OF ENCORE LINEAR POROUS COATED HIP

K-Number: K991325 · 1999-06-25

Decision Date1999-06-25

Product CodeLPH

Advisory CommitteeOR

DecisionSubstantially Equivalent

Device Summary

MODIFICATION OF ENCORE LINEAR POROUS COATED HIP is the device name listed in this FDA 510(k) record. The listed applicant is Encore Orthopedics, Inc.. It received FDA 510(k) clearance on 1999-06-25 under 510(k) number K991325. The device is classified under product code LPH. It was reviewed by the OR advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the MODIFICATION OF ENCORE LINEAR POROUS COATED HIP?

MODIFICATION OF ENCORE LINEAR POROUS COATED HIP is a medical device that received FDA 510(k) clearance on 1999-06-25. The listed applicant is Encore Orthopedics, Inc.. The 510(k) number is K991325.

When did MODIFICATION OF ENCORE LINEAR POROUS COATED HIP receive FDA 510(k) clearance?

MODIFICATION OF ENCORE LINEAR POROUS COATED HIP received FDA 510(k) clearance on 1999-06-25, under 510(k) number K991325.

Who is the listed applicant for MODIFICATION OF ENCORE LINEAR POROUS COATED HIP?

The FDA 510(k) record lists Encore Orthopedics, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for MODIFICATION OF ENCORE LINEAR POROUS COATED HIP?

The FDA product code for MODIFICATION OF ENCORE LINEAR POROUS COATED HIP is LPH.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITING NCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITING NCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDED NCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Encore Orthopedics, Inc. as applicant

K0329053DKNEE POROUS COATED FEMORAL COMPONENT K0201143D KNEE K020741UNICONDYLAR KNEE K020236MODIFICATION TO PASS SPINAL SYSTEM K020170KEYSTONE HIP SYSTEM CALCAR REPLACEMENT BODY AND BUILD UP K013490CEMENTED CALCAR HIP SYSTEM

View all 85 devices →

Related Devices (Code: LPH)

K261453G7® Acetabular SystemZimmer Biomet K253630Mpact 3D Metal FoamMedacta International S.A.K254043TRIVANCE™ Hip StemGlobus Medical, Inc.K261624Omnifit® 20° Series I Insert;Omnifit® Crossfire® 10° Series II Insert; Constrained Acetabular Insert; Trident® Crossfire® 0° Polyethylene Insert; Trident ® Crossfire ® 10° Polyethylene Insert;System 12 Crossfire® 10° Insert; Trident® 0° Constrained Acetabular Insert; Trident® Constrained Acetabular Liner;Trident® All Poly Constrained Acetabular Insert; Crossfire® Eccentric Insert 10°; Artisan® Bone Plug;UHR® Universal Head Bipolar ComponentHowmedica Osteonics Corp., Dba Stryker Orthopaedics K243192iNSitu Lateralized Acetabular Liners, iNSitu Femoral Stems with Plasma Sprayed CPTi CoatingNextstep Arthopedix, LLC K251270Taperloc® Complete Hip StemBiomet, Inc.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.